Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro
Immunomodulation is an important part of lenalidomide's mode of action. We analyzed the impact of lenalidomide on T cells from patients with multiple myeloma during lenalidomide therapy in vivo and in patients with lenalidomide-refractory disease in vitro Patients enrolled in the German Speakin...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
31 May 2016
|
| In: |
OncoImmunology
Year: 2016, Jahrgang: 5, Heft: 5, Pages: 1-10 |
| ISSN: | 2162-402X |
| DOI: | 10.1080/2162402X.2016.1139662 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/2162402X.2016.1139662
|
| Verfasserangaben: | Isabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, Brigitte Neuber, Sergej Medenhoff, Uta Bertsch, Jens Hillengass, Marc-Steffen Raab, Dirk Hose, Anthony D. Ho, Hartmut Goldschmidt & Michael Hundemer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1698801769 | ||
| 003 | DE-627 | ||
| 005 | 20230427091741.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200526s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/2162402X.2016.1139662 |2 doi | |
| 035 | |a (DE-627)1698801769 | ||
| 035 | |a (DE-599)KXP1698801769 | ||
| 035 | |a (OCoLC)1341326438 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Krämer, Isabelle |d 1984- |e VerfasserIn |0 (DE-588)1025613481 |0 (DE-627)723627738 |0 (DE-576)370555724 |4 aut | |
| 245 | 1 | 0 | |a Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro |c Isabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, Brigitte Neuber, Sergej Medenhoff, Uta Bertsch, Jens Hillengass, Marc-Steffen Raab, Dirk Hose, Anthony D. Ho, Hartmut Goldschmidt & Michael Hundemer |
| 264 | 1 | |c 31 May 2016 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 26.05.2020 | ||
| 520 | |a Immunomodulation is an important part of lenalidomide's mode of action. We analyzed the impact of lenalidomide on T cells from patients with multiple myeloma during lenalidomide therapy in vivo and in patients with lenalidomide-refractory disease in vitro Patients enrolled in the German Speaking Myeloma Multicenter Group (GMMG) MM5 trial received a consolidation therapy with two cycles of lenalidomide after autologous stem cell transplantation (ASCT). Half of the study population continued treatment with lenalidomide maintenance therapy for 2 y, while the other patients received lenalidomide maintenance therapy until complete remission. We analyzed 58 patients with (n = 30) or without (n = 28) lenalidomide therapy and 12 patients refractory to lenalidomide with regards to their anti-myeloma-specific T-cell responses displayed by IFNγ, Granzyme B, and Perforin secretion. The immunophenotype of T-cells was investigated by flow cytometry. Significantly, more myeloma-specific T-cell responses were observed in patients during lenalidomide therapy, compared to patients without treatment. Furthermore, we found on T-cells from patients treated with lenalidomide a decreased CD45RA expression, indicating a maturated immunophenotype and a decreased expression of CD57, indicating functional T cells. An improved myeloma-specific T-cell response was observed in 6 out of 12 heavily pretreated patients (refractory to lenalidomide) after in vitro incubation with lenalidomide. Complementary to the results in vivo, lenalidomide decreased CD45RA expression on T cells in vitro. | ||
| 650 | 4 | |a Antigen-specific T-cells | |
| 650 | 4 | |a CD45RA | |
| 650 | 4 | |a CD57 | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a lenalidomide | |
| 650 | 4 | |a multiple myeloma | |
| 700 | 1 | |a Engelhardt, Melanie |d 1980- |e VerfasserIn |0 (DE-588)1045014486 |0 (DE-627)773400761 |0 (DE-576)398327106 |4 aut | |
| 700 | 1 | |a Fichtner, Sabrina |e VerfasserIn |0 (DE-588)1210954923 |0 (DE-627)1698829280 |4 aut | |
| 700 | 1 | |a Neuber, Brigitte |d 1974- |e VerfasserIn |0 (DE-588)1052913563 |0 (DE-627)789293188 |0 (DE-576)408653884 |4 aut | |
| 700 | 1 | |a Medenhoff, Sergej |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bertsch, Uta |e VerfasserIn |0 (DE-588)1026849861 |0 (DE-627)727494163 |0 (DE-576)372176224 |4 aut | |
| 700 | 1 | |a Hillengaß, Jens |d 1974- |e VerfasserIn |0 (DE-588)124918549 |0 (DE-627)368073823 |0 (DE-576)294568298 |4 aut | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |e VerfasserIn |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 aut | |
| 700 | 1 | |a Hose, Dirk |d 1969- |e VerfasserIn |0 (DE-588)139824995 |0 (DE-627)613790308 |0 (DE-576)313431698 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Hundemer, Michael |d 1972- |e VerfasserIn |0 (DE-588)128390549 |0 (DE-627)372634001 |0 (DE-576)297117998 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoImmunology |d Abingdon : Taylor & Franics, 2012 |g 5(2016,5) Artikel-Nummer e1139662, 10 seiten |h Online-Ressource |w (DE-627)683365428 |w (DE-600)2645309-5 |w (DE-576)356728366 |x 2162-402X |7 nnas |a Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro |
| 773 | 1 | 8 | |g volume:5 |g year:2016 |g number:5 |g pages:1-10 |g extent:10 |a Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro |
| 856 | 4 | 0 | |u https://doi.org/10.1080/2162402X.2016.1139662 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200526 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 128390549 |a Hundemer, Michael |m 128390549:Hundemer, Michael |d 910000 |d 910100 |e 910000PH128390549 |e 910100PH128390549 |k 0/910000/ |k 1/910000/910100/ |p 12 |y j | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |e 910000PG102258023X |e 910100PG102258023X |k 0/910000/ |k 1/910000/910100/ |p 11 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 10 | ||
| 998 | |g 139824995 |a Hose, Dirk |m 139824995:Hose, Dirk |d 910000 |d 910100 |d 50000 |e 910000PH139824995 |e 910100PH139824995 |e 50000PH139824995 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 9 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |d 910100 |e 910000PR124052460 |e 910100PR124052460 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 124918549 |a Hillengaß, Jens |m 124918549:Hillengaß, Jens |d 910000 |d 910100 |e 910000PH124918549 |e 910100PH124918549 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 1026849861 |a Bertsch, Uta |m 1026849861:Bertsch, Uta |d 910000 |d 910100 |e 910000PB1026849861 |e 910100PB1026849861 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 1052913563 |a Neuber, Brigitte |m 1052913563:Neuber, Brigitte |d 910000 |d 910100 |e 910000PN1052913563 |e 910100PN1052913563 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1210954923 |a Fichtner, Sabrina |m 1210954923:Fichtner, Sabrina |d 910000 |d 910100 |e 910000PF1210954923 |e 910100PF1210954923 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1045014486 |a Engelhardt, Melanie |m 1045014486:Engelhardt, Melanie |d 910000 |d 910100 |e 910000PE1045014486 |e 910100PE1045014486 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1025613481 |a Krämer, Isabelle |m 1025613481:Krämer, Isabelle |d 910000 |d 910100 |e 910000PK1025613481 |e 910100PK1025613481 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1698801769 |e 3671159308 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"role":"aut","given":"Isabelle","display":"Krämer, Isabelle","family":"Krämer"},{"role":"aut","given":"Melanie","display":"Engelhardt, Melanie","family":"Engelhardt"},{"given":"Sabrina","role":"aut","display":"Fichtner, Sabrina","family":"Fichtner"},{"role":"aut","given":"Brigitte","family":"Neuber","display":"Neuber, Brigitte"},{"family":"Medenhoff","display":"Medenhoff, Sergej","role":"aut","given":"Sergej"},{"given":"Uta","role":"aut","display":"Bertsch, Uta","family":"Bertsch"},{"family":"Hillengaß","display":"Hillengaß, Jens","role":"aut","given":"Jens"},{"display":"Raab, Marc-Steffen","family":"Raab","role":"aut","given":"Marc-Steffen"},{"display":"Hose, Dirk","family":"Hose","role":"aut","given":"Dirk"},{"family":"Ho","display":"Ho, Anthony Dick","role":"aut","given":"Anthony Dick"},{"given":"Hartmut","role":"aut","display":"Goldschmidt, Hartmut","family":"Goldschmidt"},{"display":"Hundemer, Michael","family":"Hundemer","role":"aut","given":"Michael"}],"id":{"doi":["10.1080/2162402X.2016.1139662"],"eki":["1698801769"]},"recId":"1698801769","relHost":[{"id":{"eki":["683365428"],"issn":["2162-402X"],"zdb":["2645309-5"]},"recId":"683365428","physDesc":[{"extent":"Online-Ressource"}],"disp":"Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitroOncoImmunology","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"OncoImmunology","title":"OncoImmunology"}],"origin":[{"publisherPlace":"Abingdon ; Austin, Tex.","dateIssuedDisp":"2012-","dateIssuedKey":"2012","publisher":"Taylor & Franics ; Landes Bioscience"}],"note":["Gesehen am 13.12.2022"],"pubHistory":["1.2012 -"],"part":{"issue":"5","text":"5(2016,5) Artikel-Nummer e1139662, 10 seiten","year":"2016","pages":"1-10","extent":"10","volume":"5"},"titleAlt":[{"title":"Onco Immunology"}],"language":["eng"]}],"name":{"displayForm":["Isabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, Brigitte Neuber, Sergej Medenhoff, Uta Bertsch, Jens Hillengass, Marc-Steffen Raab, Dirk Hose, Anthony D. Ho, Hartmut Goldschmidt & Michael Hundemer"]},"physDesc":[{"extent":"10 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 26.05.2020"],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"31 May 2016"}],"title":[{"title":"Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro","title_sort":"Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro"}]} | ||
| SRT | |a KRAEMERISALENALIDOMI3120 | ||